Latest news
Loading news…
ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.
ValenzaBio was acquired by ACELYRIN in 2023.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
7
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Bethesda, Maryland, United States
Key People at ValenzaBio
Co-Founder and General Counsel
7
professional contacts at ValenzaBio
Contact execs at ValenzaBio →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to ValenzaBio
Loading news…
FAQs about ValenzaBio
People who checked this page also checked these
Browse the full Acquirezy directory.